milnacipran has been researched along with reserpine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asaki, T; Hasegawa, M; Ishida, M; Shinohara, S; Tamano, R | 1 |
1 review(s) available for milnacipran and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for milnacipran and reserpine
| Article | Year |
|---|---|
Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors.
Topics: Administration, Cutaneous; Analgesics; Animals; Biogenic Monoamines; Brain; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Injections, Spinal; Milnacipran; Neurons; Norepinephrine; Pain Threshold; Rats, Sprague-Dawley; Reserpine; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Spinal Cord; Vesicular Monoamine Transport Proteins | 2016 |